The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Acne vulgaris: A review of the pathophysiology, treatment, and recent nanotechnology based advances
Open accessAbstract
Background: Globally, Acne Vulgaris is a widespread, chronic inflammatory condition of the pilosebaceous follicles. Acne is not fatal, but depending on its severity, it can leave the sufferer with scars, irritation, and significant psychological effects (including depression). In the current review, we have included various factors for acne and their treatment explained. It also narrated the current medicament and the new investigation dosage forms with clinical phases information provided. Main body of the abstract: Acne's pathophysiology involves four important factors: excessive sebum production, hyperkeratinization of pilosebaceous follicles, hyperproliferation of propionibacterium acnes (P. acnes), and inflammation. Identifying both inflammatory (Papule, pustule, nodule, and cyst) and non-inflammatory (black heads, white heads) acne lesions is necessary for diagnosing and treating acne vulgaris. Short conclusion: In this review, traditional therapy approaches such as topical (i.e., retinoids and antibiotics), systemic (i.e., retinoids, antibiotics, and hormonal), and physical therapies are briefly discussed. In addition, we highlight the issues posed by P. acne's resistance to the antibiotics used in commercially available medications and the necessity for novel therapeutic techniques. Finally, we examined a few innovative acne therapies pending clinical trial approval and commercial acne medications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Byrd, A. L., Belkaid, Y., & Segre, J. A. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.157 · Cited by 2,806
50 Years of Topical Retinoids for Acne: Evolution of Treatment
Baldwin, H., Webster, G., Stein Gold, L., Callender, V., Cook-Bolden, F. E., & Guenin, E. (2021) · American Journal of Clinical Dermatology · doi:10.1007/s40257-021-00594-8 · Cited by 82
Interventions to increase adherence to acne treatment
Moradi Tuchayi, S., Alexander, T., Nadkarni, A., & Feldman, S. R. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s117437 · Cited by 78
Zheng, Y., Yin, S., Xia, Y., Chen, J., Ye, C., Zeng, Q., & Lai, W. (2019) · Cutaneous and Ocular Toxicology · doi:10.1080/15569527.2018.1518329 · Cited by 43 · cited 1×
“Initially, 6 – 8 weeks acne patients can be treated with BPO mono-therapy, but for effective results, BPO is combined with topical antibiotics to minimize P. acne species resistance and promotes therapeutic efficacy [50].”
Background
Cited by
Abedin, Z. U., Shah, A., Mazhar, S., Khan, S. M., Aamir, A. B., Yousaf, S., Fnu, D., Mahato, R. K., & Ansari, A. (2026) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.70792 · Cited by 5
The Impact of Probiotics on Acne Vulgaris: A Meta-Analysis of Randomized Controlled Trials
Mohamed, M., Ullah, A., Hassan, R., Hamza, M., Mohamed, I., & Salam, M. (2025) · Cureus · doi:10.7759/cureus.97010 · Cited by 5
Metadata
- Authors
- Vasam, M., Korutla, S., & Bohara, R. A.
- Venue
- Biochemistry and Biophysics Reports
- Publisher
- Elsevier BV
- Published
- 2023-12
- Volume
- 36
- Pages
- 101578
- ISSN
- 2405-5808 (ISSN-L)
- OpenAlex
- W4388962250
- Cited by
- 231
- References
- 4
- FWCI
- 52.27
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Acne vulgaris: A review of the pathophysiology, treatment, and recent nanotechnology based advances. https://app.cochat.ai/papers/10.1016/j.bbrep.2023.101578
- The paper
- Vasam, M., Korutla, S., & Bohara, R. A. (2023). Acne vulgaris: A review of the pathophysiology, treatment, and recent nanotechnology based advances. Biochemistry and Biophysics Reports. https://doi.org/10.1016/j.bbrep.2023.101578
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.